Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661241 · ClinicalTrials.gov registry record · NA
Mapping the Target for the MRgFUS Treatment of Tremor
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04661241: Completed NA study, sponsored by NYU Langone Health.
NCT04661241 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04661241, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this investigation is to determine the optimal DRT/VIM target location and its safety margins based on MR-SISET imaging features by comparing with postoperative lesions and clinical outcomes in patients with tremor who will undergo the MRgFUS tremor therapy.
Primary Outcome
A routine clinical follow-up will be performed to assess the severity of tremor after the treatment (\~ 6 weeks) by the clinician. Patients will be categorized into three groups based on their outcome: a good clinical outcome (\>65% tremor improvement), a moderate outcome (\>33%, but \<66% tremor improvement) and a poor outcome (\<33% tremor improvement).
Interventions
- OTHER Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches
- OTHER Routine clinical MRI protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
What the finished NCT04661241 record still lists
NCT04661241 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches is the first listed.
NCT04661241 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04661241 about?
NCT04661241 is a clinical study titled "Mapping the Target for the MRgFUS Treatment of Tremor". The purpose of this investigation is to determine the optimal DRT/VIM target location and its safety margins based on MR-SISET imaging features by comparing with postoperative lesions and clinical outcomes in patients with tremor who will undergo the MRgFUS tremor therapy.
What is the current status of trial NCT04661241?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-09-10. Estimated completion is 2022-06-15.
What interventions are being tested in trial NCT04661241?
The interventions under investigation include: Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches (OTHER), Routine clinical MRI protocol (OTHER).
Who is sponsoring clinical trial NCT04661241?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04661241's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI